Relationship between outer membrane protein profiles and resistance to ceftazidime, imipenem, and ciprofloxacin in Pseudomonas aeruginosa isolates from bacteremic patients
- PMID: 8641311
- DOI: 10.1007/BF01586192
Relationship between outer membrane protein profiles and resistance to ceftazidime, imipenem, and ciprofloxacin in Pseudomonas aeruginosa isolates from bacteremic patients
Abstract
Outer membrane protein (OMP) profiles of 122 Pseudomonas aeruginosa isolates recovered from the blood of bacteremic patients were analyzed to relate alterations in the expression of OMPs with porin activity to resistance to imipenem, ceftazidime, and ciprofloxacin. Imipenem-resistant isolates lacked or expressed reduced amounts of porin OprD. In contrast, alterations of OMP profiles were absent in most ceftazidime-resistant isolates. Six of 12 ciprofloxacin-resistant isolates had normal OMP profiles. The remaining isolates showed alterations in the expression of either OprC, OprF, or OprD. In addition, imipenem- and ceftazidime-resistant isolates displayed a beta-lactamase activity compatible with that of a group 1 chromosomal cephalosporinase.
Similar articles
-
Susceptibility of Pseudomonas aeruginosa isolates to ceftazidime is unrelated to the expression of the outer membrane protein OprC.Chemotherapy. 1997 Jan-Feb;43(1):27-30. doi: 10.1159/000239531. Chemotherapy. 1997. PMID: 8996738
-
In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.Eur J Clin Microbiol Infect Dis. 1997 Feb;16(2):159-62. doi: 10.1007/BF01709477. Eur J Clin Microbiol Infect Dis. 1997. PMID: 9105845
-
Meropenem permeation through the outer membrane of Pseudomonas aeruginosa can involve pathways other than the OprD porin channel.Chemotherapy. 1996 May-Jun;42(3):210-14. doi: 10.1159/000239444. Chemotherapy. 1996. PMID: 8983889
-
Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials.Clin Infect Dis. 1997 Feb;24 Suppl 2:S191-6. doi: 10.1093/clinids/24.supplement_2.s191. Clin Infect Dis. 1997. PMID: 9126693
-
In vitro activity of ceftazidime, cefepime and imipenem on 1,005 Pseudomonas aeruginosa clinical isolates either susceptible or resistant to beta-lactams.Chemotherapy. 2000 Jul-Aug;46(4):229-34. doi: 10.1159/000007294. Chemotherapy. 2000. PMID: 10859428
Cited by
-
In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates.Antimicrob Agents Chemother. 2005 Oct;49(10):4413-7. doi: 10.1128/AAC.49.10.4413-4417.2005. Antimicrob Agents Chemother. 2005. PMID: 16189137 Free PMC article.